United States · FDA National Drug Code directory

CHOLESTYRAMINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
24658-266_7c3a3854-b045-4b67-ba97-eb980be64817
Product NDC
24658-266
Form
POWDER, FOR SUSPENSION
Composition / generic term
cholestyramine
Labeler
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Marketing category
ANDA
Marketing start / end (source format)
20230314
Source listing expiry
20261231

Source-listed ingredients

  • CHOLESTYRAMINE — 4 g/9g

These values do not establish equivalence or a dose recommendation.

Packages

  • 378 g in 1 JAR (24658-266-93) · 24658-266-93
  • 60 POUCH in 1 CARTON (24658-266-95) / 9 g in 1 POUCH · 24658-266-95
  • 378 g in 1 CAN (24658-266-97) · 24658-266-97

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →